These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21769943)

  • 21. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of recombinant human antithrombin III in Pichia pastoris.
    Mochizuki S; Hamato N; Hirose M; Miyano K; Ohtani W; Kameyama S; Kuwae S; Tokuyama T; Ohi H
    Protein Expr Purif; 2001 Oct; 23(1):55-65. PubMed ID: 11570846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.
    Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J
    Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
    Desai UR; Petitou M; Björk I; Olson ST
    J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
    Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
    J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of antithrombin in a heparin-bound intermediate state.
    Johnson DJ; Huntington JA
    Biochemistry; 2003 Jul; 42(29):8712-9. PubMed ID: 12873131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dynamics simulations of CXCL-8 and its interactions with a receptor peptide, heparin fragments, and sulfated linked cyclitols.
    Gandhi NS; Mancera RL
    J Chem Inf Model; 2011 Feb; 51(2):335-58. PubMed ID: 21299226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
    Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural effects of a covalent linkage between antithrombin and heparin: covalent N-terminus attachment of heparin enhances the maintenance of antithrombin's activated state.
    Mewhort-Buist TA; Junop M; Berry LR; Chindemi P; Chan AK
    J Biochem; 2006 Aug; 140(2):175-84. PubMed ID: 16954536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation.
    Monien BH; Krishnasamy C; Olson ST; Desai UR
    Biochemistry; 2005 Sep; 44(35):11660-8. PubMed ID: 16128566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure.
    Fan B; Crews BC; Turko IV; Choay J; Zettlmeissl G; Gettins P
    J Biol Chem; 1993 Aug; 268(23):17588-96. PubMed ID: 8349638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin binding site, conformational change, and activation of antithrombin.
    Evans DL; Marshall CJ; Christey PB; Carrell RW
    Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformation of heparin pentasaccharide bound to antithrombin III.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Petitou M; Casu B
    Biochem J; 2001 Oct; 359(Pt 2):265-72. PubMed ID: 11583572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.